PyroGenesis Canada (PYRGF) Competitors $0.36 +0.00 (+0.06%) (As of 12/20/2024 05:32 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends PYRGF vs. ACIU, AMLX, LFCR, ITOS, BNTC, FHTX, LRMR, ELDN, AVIR, and URGNShould you be buying PyroGenesis Canada stock or one of its competitors? The main competitors of PyroGenesis Canada include AC Immune (ACIU), Amylyx Pharmaceuticals (AMLX), Lifecore Biomedical (LFCR), iTeos Therapeutics (ITOS), Benitec Biopharma (BNTC), Foghorn Therapeutics (FHTX), Larimar Therapeutics (LRMR), Eledon Pharmaceuticals (ELDN), Atea Pharmaceuticals (AVIR), and UroGen Pharma (URGN). These companies are all part of the "pharmaceutical products" industry. PyroGenesis Canada vs. AC Immune Amylyx Pharmaceuticals Lifecore Biomedical iTeos Therapeutics Benitec Biopharma Foghorn Therapeutics Larimar Therapeutics Eledon Pharmaceuticals Atea Pharmaceuticals UroGen Pharma PyroGenesis Canada (NASDAQ:PYRGF) and AC Immune (NASDAQ:ACIU) are both small-cap industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership, community ranking and dividends. Does the MarketBeat Community favor PYRGF or ACIU? AC Immune received 258 more outperform votes than PyroGenesis Canada when rated by MarketBeat users. CompanyUnderperformOutperformPyroGenesis CanadaN/AN/AAC ImmuneOutperform Votes25862.47% Underperform Votes15537.53% Do insiders & institutionals have more ownership in PYRGF or ACIU? 0.0% of PyroGenesis Canada shares are owned by institutional investors. Comparatively, 51.4% of AC Immune shares are owned by institutional investors. 47.7% of PyroGenesis Canada shares are owned by insiders. Comparatively, 4.6% of AC Immune shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more volatility and risk, PYRGF or ACIU? PyroGenesis Canada has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, AC Immune has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500. Is PYRGF or ACIU more profitable? AC Immune has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. AC Immune's return on equity of -28.26% beat PyroGenesis Canada's return on equity.Company Net Margins Return on Equity Return on Assets PyroGenesis Canada-115.14% -1,365.53% -60.81% AC Immune N/A -28.26%-18.98% Does the media prefer PYRGF or ACIU? In the previous week, AC Immune had 1 more articles in the media than PyroGenesis Canada. MarketBeat recorded 1 mentions for AC Immune and 0 mentions for PyroGenesis Canada. AC Immune's average media sentiment score of 1.08 beat PyroGenesis Canada's score of 0.00 indicating that AC Immune is being referred to more favorably in the news media. Company Overall Sentiment PyroGenesis Canada Neutral AC Immune Positive Do analysts recommend PYRGF or ACIU? AC Immune has a consensus target price of $12.00, indicating a potential upside of 347.76%. Given AC Immune's stronger consensus rating and higher possible upside, analysts clearly believe AC Immune is more favorable than PyroGenesis Canada.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00AC Immune 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, PYRGF or ACIU? PyroGenesis Canada has higher earnings, but lower revenue than AC Immune. PyroGenesis Canada is trading at a lower price-to-earnings ratio than AC Immune, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPyroGenesis Canada$9.14M7.25-$21.12M-$0.06-6.00AC Immune$40.97M6.47-$60.41M-$0.46-5.83 SummaryAC Immune beats PyroGenesis Canada on 13 of the 17 factors compared between the two stocks. Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. Get PyroGenesis Canada News Delivered to You Automatically Sign up to receive the latest news and ratings for PYRGF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYRGF vs. The Competition Export to ExcelMetricPyroGenesis CanadaPharmaceutical IndustryIndustrial SectorNASDAQ ExchangeMarket Cap$66.22M$6.57B$9.24B$9.08BDividend YieldN/A3.00%2.10%4.23%P/E Ratio-6.0010.5921.0817.18Price / Sales7.25195.804.86116.99Price / CashN/A57.1619.2537.86Price / Book-36.005.094.224.78Net Income-$21.12M$151.83M$398.18M$225.60M7 Day Performance-12.30%-2.13%-4.86%-1.23%1 Month Performance-24.46%-3.10%-2.10%3.36%1 Year Performance13.10%11.54%14.80%16.60% PyroGenesis Canada Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYRGFPyroGenesis CanadaN/A$0.36+0.1%N/A+15.9%$66.22M$9.14M-6.0090ACIUAC Immune2.4741 of 5 stars$2.97+0.7%$12.00+304.0%-33.8%$293.85M$16.48M-6.41140Positive NewsAMLXAmylyx Pharmaceuticals4.2561 of 5 stars$4.20+1.9%$7.33+74.6%-70.7%$287.90M$196.49M-1.08200Short Interest ↓News CoveragePositive NewsLFCRLifecore Biomedical2.9045 of 5 stars$7.75+1.8%$10.00+29.0%+18.7%$285.41M$128.44M97.50690ITOSiTeos Therapeutics3.5018 of 5 stars$7.74+0.8%$25.25+226.2%-28.4%$282.77M$35M-2.4490Analyst ForecastBNTCBenitec Biopharma3.6885 of 5 stars$12.13+3.1%$24.43+101.4%+277.8%$281.66M$80,000.000.0020Analyst RevisionFHTXFoghorn Therapeutics2.8809 of 5 stars$4.97-6.2%$16.00+221.9%-14.0%$276.30M$25.52M-2.63120Analyst ForecastAnalyst RevisionNews CoverageGap DownHigh Trading VolumeLRMRLarimar Therapeutics1.5624 of 5 stars$4.31-30.1%$20.43+374.0%+4.4%$275.02MN/A-3.5630Analyst RevisionNews CoveragePositive NewsGap DownHigh Trading VolumeELDNEledon Pharmaceuticals2.9252 of 5 stars$4.54+3.7%$16.00+252.4%+196.6%$271.22MN/A-2.3310Positive NewsAVIRAtea Pharmaceuticals3.0689 of 5 stars$3.19+8.9%$6.88+115.7%+5.6%$269.44M$351.37M-1.5370High Trading VolumeURGNUroGen Pharma3.8754 of 5 stars$11.43+0.7%$43.70+282.3%-28.4%$268.03M$82.71M-3.60200 Related Companies and Tools Related Companies ACIU Alternatives AMLX Alternatives LFCR Alternatives ITOS Alternatives BNTC Alternatives FHTX Alternatives LRMR Alternatives ELDN Alternatives AVIR Alternatives URGN Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PYRGF) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PyroGenesis Canada Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PyroGenesis Canada With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.